Navigation Links
Certain probiotics could help women lose weight
Date:1/28/2014

Quebec City, January 28, 2014Certain probiotics could help women lose weight and keep it off, according to a recent study published in the British Journal of Nutrition by a team of researchers headed by Universit Laval Professor Angelo Tremblay.

Studies have already demonstrated that the intestinal flora of obese individuals differs from that of thin people. That difference may be due to the fact that a diet high in fat and low in fiber promotes certain bacteria at the expense of others. Professor Tremblay and his team tried to determine if the consumption of probiotics could help reset the balance of the intestinal microbiota in favor of bacteria that promote a healthy weight.

To test their hypothesis, researchers recruited 125 overweight men and women. The subjects underwent a 12-week weight-loss diet, followed by a 12-week period aimed at maintaining body weight. Throughout the entire study, half the participants swallowed 2 pills daily containing probiotics from the Lactobacillus rhamnosus family, while the other half received a placebo.

After the 12-week diet period, researchers observed an average weight loss of 4.4 kg in women in the probiotic group and 2.6 kg in the placebo group. However, no differences in weight loss were observed among males in the two groups. "We don't know why the probiotics didn't have any effect on men. It may be a question of dosage, or the study period may have been too short," says Professor Tremblay, who is also the Canada Research Chair in Environment and Energy Balance.

After the 12-week maintenance period, the weight of the women in the placebo group had remained stable but the probiotic group had continued to lose weight, for a total of 5.2 kg per person. In short, women consuming probiotics lost twice as much weight over the 24-week period of the study. Researchers also noted a drop in the appetite-regulating hormone leptin in this group, as well as a lower overall concentration of the intestinal bacteria related to obesity.

According to Angelo Tremblay, probiotics may act by altering the permeability of the intestinal wall. By keeping certain proinflammatory molecules from entering the bloodstream, they might help preventing the chain reaction that leads to glucose intolerance, type 2 diabetes, and obesity.

The Lactobacillus rhamnosus strain used in this study belongs to Nestl, which uses it in certain yogurts it makes for the European market, but Professor Tremblay believes that the probiotics found in dairy products in North America could have a similar effect to the Nestl strain. He stresses, however, that the benefits of these bacteria are more likely to be observed in a favorable nutritional context that promotes low fat and adequate fiber intake.


'/>"/>
Contact: Jean-François Huppé
jean-francois.huppe@dc.ulaval.ca
418-656-7785
Universit Laval
Source:Eurekalert

Related medicine news :

1. Melatonin shows potential to slow tumor growth in certain breast cancers
2. Vaginal Mesh Lawsuit News: C.R. Bard Motion to Exclude Certain Evidence Denied in Federal Bellwether Trial, Bernstein Liebhard LLP Reports
3. Research shows molecular, protein targeting therapies may be best treatment for certain lung cancer
4. No brakes -- Study finds mechanism for increased activity of oncogene in certain cancers
5. Small Business Majority -- 2013 Spells Year of Big Changes, Uncertainty for America’s Small Business Community
6. Patience Will Certainly Be a Virtue Believes Carol Newman as the Biogirl Health Show Explores the Latest Changes in the Affordable Care Act
7. Certain symptom clusters experienced after surgery for esophageal cancer predict poor prognosis
8. Wright Hip Lawsuit News: Federal Judge Allows Certain Claims to Proceed in Wright Profemur Hip Replacement Lawsuit, Bernstein Liebhard LLP Reports
9. New nanopharmaceutical may help overcome resistance to certain anticancer drugs
10. EPA Action to Restrict Imports of Certain Perfluorinated Chemicals (PFCs) Draws Praise from C-8 Lawsuit Lawyers at Wright & Schulte LLC
11. Physicians experience increased effort, uncertainty in cross-coverage of radiation oncology patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a ... and business owners in North Central West Virginia, is embarking on a cooperative ... abled residents in the region. , The Stepping Stones organization offers a series ...
(Date:6/22/2017)... California (PRWEB) , ... June 22, 2017 , ... Groove ... spread the word about their high performance silicon wedding bands and all-purpose rings. Whether ... are the active, silicone rings designed just for you. , From the rock face ...
(Date:6/22/2017)... ... June 22, 2017 , ... A June 12 article in ... about an apparent lack of oral hygiene by an aged parent who had recently ... matters, suggests a number of steps, including scheduling a dentist visit. Northridge Dental Works, ...
(Date:6/20/2017)... York City (PRWEB) , ... June 20, 2017 , ... After months of negotiations, FaceCradle ... QVC Network on Wednesday, June 21. , “Introducing our product on QVC is ... for us to promote our travel pillow to more than 90 million homes in the ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... the introduction of school choice can promote economic development in economically distressed urban ... has, according to the report, contributed to the economic development of the city ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... , May 22, 2017  As the ... a whole continue to make the revolutionary shift ... increasingly important for ensuring positive patient outcomes and ... stakeholders are shifting focus away from clinical trials ... effects of long-term specialty drug therapy utilization in ...
(Date:5/18/2017)... WHIPPANY, N.J. , May 17, 2017  Bayer ... growing oncology portfolio will be presented at the 53 ... Clinical Oncology (ASCO), taking place June 2-6 in ... being presented at ASCO span prostate, colorectal, liver and ... subgroup analysis from the Phase II CHRONOS-1 trial of ...
(Date:5/15/2017)... , May 15, 2017 Enterin Inc., a ... and developing novel compounds to treat Parkinson,s disease (PD), ... study is a Phase 1/2a randomized, controlled, multicenter study involving ... It will enroll 50 patients over a 9-to-12-month period. The ... in 10 patients with PD. Participating sites include ...
Breaking Medicine Technology: